Evidence map›Paper›PMID 32696084›Full record

ArticleJournal of materials science. Materials in medicine2020

Osseointegration around dental implants biofunctionalized with TGFβ-1 inhibitor peptides: an in vivo study in beagle dogs.

Andrea Cirera, Pablo Sevilla, M Cristina Manzanares, Jordi Franch, Pablo Galindo-Moreno, Javier Gil

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of materials science. Materials in medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Andrea CireraOral Surgery and Implant Dentistry Department, School of Dentistry, University of Granada, Campus Universitario La Cartuja s/n, Barcelona, Spain.
Pablo SevillaEscola Universitària Salesiana de Sarrià - EUSS Autonomous University of Barcelona, Barcelona, Spain. psevilla@euss.es.ORCID http://orcid.org/0000-0002-8335-0318
M Cristina ManzanaresHuman Anatomy and Embryology Unit, DPyTEx, School of Medicine, University of Barcelona, Barcelona, Spain.
Jordi FranchSurgery Department, Veterinary School, Autonomous University of Barcelona, Bellaterra, Barcelona, Spain.
Pablo Galindo-MorenoOral Surgery and Implant Dentistry Department, School of Dentistry, University of Granada, Barcelona, Spain.
Javier GilUniversitat Internacional de Catalunya, Facultat de Medicina i Ciències de la Salut, Barcelona, Spain.
Universidad de Granada · ESUniversitat Autònoma de Barcelona · ESUniversitat de Barcelona · ESUniversitat Internacional de Catalunya · ES

Funding

CSRD VA 1
6 · The paper itself

Abstract

The aim of this study was to evaluate the effect of biofunctionalization with two TGF-β1 inhibitor peptides, P17 and P144, on osseointegration of CP-Ti dental implants. A total of 36 implants (VEGA, Klockner®) with 3.5 × 8 mm internal connection were used in this study, divided in three groups: (1) control group (n = 12), (2) implants which surfaces were biofunctionalized with P17 peptide inhibitor (n = 12), (3) implants with surfaces biofunctionalized by P144 peptide (n = 12). Three implants, one from each group, were inserted in both hemimandibles of 6 beagle dogs, 2 months after tooth extraction. Two animals were sacrificed at 2, 4 and 8 weeks post implant insertion, respectively. The samples were analyzed by Backscattering Scanning Electron Microscopy (BS-SEM) and histological analysis. Histomorphometric analysis of bone to implant contact (BIC), peri-implant bone fraction (BF) and interthread bone (IB) were carried out. Bone formation around implants measured by quantitative analysis, BS-SEM, was significantly higher in the P17-biofunctionalized implants, 4 and 8 weeks after the implantation. Histomorphometric analysis of BIC, BF and IB showed higher values in the P17-biofunctionalized group at initial stages of healing (2 weeks) and early osseointegration both at 4 and 8 weeks. For P144 biofunctionalized implants, the histomorphometric values obtained are also higher than control group. Accordingly, better results in the experimental groups were proven both by the quantitative and the qualitative analysis. Surface biofunctionalization with TGF-β1 inhibitor peptides, P17 and P144, resulted in better quantitative and qualitative parameters relative to implant osseointegration.

Indexed as

Dental ImplantsAnimalsCoated Materials, BiocompatibleDental Implantation, EndosseousDental Prosthesis DesignDogsImplants, ExperimentalMaleMandibleMaterials TestingOsseointegrationOsteogenesisPeptide FragmentsPeptidesReceptors, Transforming Growth Factor betaSurface PropertiesCoated Materials, BiocompatibleDental ImplantsP17 peptidePeptide FragmentsPeptidesReceptors, Transforming Growth Factor betaTGF-beta1 type III receptor (730-743), humanTransforming Growth Factor beta1

Identifiers

PMID32696084
OpenAlexW3044407587

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.